贫血是慢性肾病（CKD）的一个常见并发症，与 CKD 的发病率和死亡率相关。重组促红细胞生成剂（ESA）可以提升透析和非透析人群的生存质量，减少红细胞输注。然而，由于 CKD 患者转诊和 ESA 药...
Anemia is a common complication of chronic kidney disease (CKD), is associated with morbidity and mortality of chronic kidney disease (CKD). Restructuring and promote erythropoiesis agent (ESA) can improve the quality of survival of dialysis and the dialysis population, reduce red blood cell transfusion. However, due to the referral and ESA drug for patients with chronic kidney disease (CKD)...
